Dermatological extemporaneously compounded products and galenicals

Dermatological ECPs will be funded if there is one or more subsidised dermatological galenical(s) in a subsidised dermatological base.

Dermatological bases can also be used to dilute proprietary Topical Corticosteroid-Plain preparations.

Part 7.5 of the Schedule Rules covers dermatological preparations

Dermatological bases

The products at the following links are all dermatological bases

Barrier creams and emollients(external link)

Topical corticosteroids - plain(external link) (except hydrocortisone powder)

Collodion flexible(external link) (Colloidon flexible has been discontinued by the manufacturer, it will be delisted in the future). 

Dermatological galenicals

Dermatological galenicals are only subsidised when added to a dermatological base. More than one dermatological galenical can be added to a dermatological base.

* Hydrocortisone powder is subsidised only in combination with a barrier cream/emollient, not with a proprietary topical corticosteroid-plain.

Is it funded?

For an ECP to be subsidised, it must contain 2 or more subsidised component pharmaceuticals listed in the Schedule.

Download the PDF for the text of this image. Sorry about the reading order..

Notes:

* Hydrocortisone powder is subsidised only in combination with a barrier cream/emollient, not with a proprietary topical corticosteroid-plain.

Information on this page is guidance only

You are responsible for making sure you comply with the lastest Schedule, including the rules in Section A.

Section A, Schedule rules part 7

Who to contact

If you have any questions, email enquiry@pharmac.govt.nz